• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. There aren't enough data regarding how exposure over time may affect the pregnant fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus do not develop neurological disorders such as hearing or vision impairment, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication should evaluate the benefits of using it against the possible risks to the foetus. Physicians don't have the information needed to make unequivocal recommendations, but they can provide information regarding benefits and risks that can aid pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy were not at a higher risk of fetal malformations or structural birth defects. Researchers conducted a massive sample-based case control study to assess the frequency of major structural defects in infants who were born to mothers who used stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts reviewed the cases in order to confirm that the classification was correct and to reduce any bias.

The study conducted by the researchers had some limitations. The researchers were unable to, in the first place, to separate the effects of the medication from the disorder. This limitation makes it difficult for researchers to establish whether the few associations observed between the exposed groups were due to the use of medications or confounded by the presence of comorbidities. The researchers also did not study long-term outcomes for offspring.

The study showed that infants whose mothers took ADHD medication during pregnancy were at a slightly greater risk of being admitted to the neonatal care unit (NICU) as compared to those whose mothers did not take any medication during pregnancy, or had stopped taking their medication before or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication that was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher chance of having to have a caesarean section or one whose baby scored low on the Apgar scale (less than 7). These risks did not seem to be influenced by the kind of medication used during pregnancy.

The researchers suggest that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy could be offset by the higher benefit to both the mother and child from continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, when possible, assist them in developing strategies to improve their coping abilities that can lessen the impact of her disorder on her daily life and relationships.

Medication Interactions

Doctors are increasingly confronted with the dilemma of whether to keep treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are usually taken without clear and authoritative evidence. Instead, physicians must take into account their own experience, the experience of other physicians and the research that has been conducted on the subject.

The issue of possible risks to the infant can be particularly tricky. The research on this issue is based on observation rather than controlled studies and a lot of the results are conflicting. The majority of studies limit their analysis to live-births, which could underestimate the severity of teratogenic effects that can lead to abortions or terminations of pregnancy. The study discussed in the journal club addresses these shortcomings, by examining both data on live and deceased births.

The conclusion The conclusion: While some studies have shown an association between ADHD medications and the risk of certain birth defects, others have found no connection and the majority of studies show a neutral or even slightly negative effect. In the end, a careful risk/benefit assessment is required in every situation.

It isn't easy, but not impossible, for women with ADHD to stop taking their medication. In fact, in an article published in Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness and family conflict for those suffering from the disorder. The loss of medication can also affect the ability to safely drive and perform work-related tasks, which are essential aspects of normal life for those with ADHD.

She suggests that women who are unsure whether to continue taking the medication or discontinue it due to pregnancy educate family members, colleagues, and friends about the condition, its impact on daily functioning and the benefits of keeping the current treatment regimen. In addition, educating them can help the woman feel supported in her struggle with her decision. It is important to note that certain drugs can pass through the placenta so if a woman decides to stop her ADHD medication during pregnancy and breastfeeding, she should be aware that the effects of the medication could be passed on to the baby.

Risk of Birth Defects

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns about the effects that the medications could have on the fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge about this subject. Researchers used two huge data sets to study more than 4.3 million pregnant women and determine whether stimulant medications increased the risk of birth defects. Researchers discovered that although the risk overall is low, the first trimester ADHD medication use was associated with slightly higher risk of certain heart defects, like ventriculoseptal defect.

The researchers of the study didn't discover any connection between early medication usage and congenital anomalies like facial deformities or club feet. The results are in agreement with previous studies that have shown an insignificant, but small increase in cardiac malformations for women who started taking ADHD medication before the time of pregnancy. The risk increased in the latter half of pregnancy when a large number of women stopped taking their medication.

Women who took ADHD medications during the first trimester of their pregnancies were also more likely to undergo caesarean sections, a low Apgar score following delivery, and a baby who required help breathing at birth. The researchers of the study could not eliminate selection bias because they limited their study to women who did not have any other medical conditions that could have contributed to the findings.

Researchers hope that their study will inform physicians when they see pregnant women. They advise that while a discussion of risks and benefits is important however, the decision to stop or keep medication should be based on each woman's needs and the severity of her ADHD symptoms.

The authors caution that, while stopping the medication is a possibility to look into, it is not recommended due to the high prevalence of depression and other mental disorders for women who are pregnant or recently gave birth. Additionally, research suggests that women who stop taking their medications will have a difficult time adjusting to a life without them once the baby is born.

Nursing

The responsibilities of being a new mother can be overwhelming. Women with adhd medication and pregnancy uk can face severe challenges when they must manage their symptoms, go to doctor appointments, prepare for the birth of a child and adjust to a new routine. Therefore, many women decide to continue taking their ADHD medications throughout the course of pregnancy.

The majority of stimulant medicines pass through breast milk in very small quantities, so the risk to the breastfeeding infant is minimal. However, the rate of exposure to medications by the newborn can vary depending on the dosage, frequency it is administered and the time of the day it is administered. In addition, various medications enter the baby’s system through the gastrointestinal tract, or through breast milk. The impact on a newborn's health is not fully comprehended.

Due to the absence of evidence, some doctors might be tempted to stop taking stimulant drugs during the pregnancy of a woman. This is a difficult decision for the patient, who must weigh the benefit of continuing her medication with the potential dangers to the foetus. As long as more information is available, GPs can inquire about pregnant patients whether they have any background of ADHD or if they plan to take medication during the perinatal stage.

Many studies have shown that women can continue taking their adhd medication pregnancy medication safely while breastfeeding and during pregnancy. In response, a growing number of patients are opting to do this. They have found after consulting with their doctor that the benefits of continuing their current medication outweigh any potential risks.

Women who suffer from ADHD who are planning to nurse should seek advice from a specialist psychiatrist before becoming pregnant. They should review their medications with their prescriber and discuss the pros and cons of continued treatment, including non-pharmacological management strategies. Psychoeducation is also necessary to help pregnant women with ADHD recognize the signs and the underlying disorder. They should also be educated about treatment options and reinforce the coping mechanisms. This should be a multidisciplinary approach with the GP doctors, obstetricians and psychiatrists. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, as well as monitoring for signs of deterioration, and, if necessary adjustments to the medication regime.